Teva Pharmaceutical has built a 4.6 per cent share of Mylan over the past months. Photographer: Akos Stiller/Bloomberg

Teva Pharmaceutical, the Israeli drugmaker, is nearing a deal to acquire Allergan’s generics drug unit for between $40 billion and $45 billion, accord(...)

Perrigo chief executive and chairman Joe Papa.  Photograph: Brenda Fitzsimons / The Irish Times

Perrigo, the Irish specialist in over the counter drugs, has agreed to buy a portfolio of products from GlaxoSmithKline. GSK’s consumer healthcare div(...)

Robert J. Coury, vice chairman and chief executive officer of Mylan told investors he may sweeten the company’s cash-and-stock offer for  Perrigo, which has rejected Mylan’s most recent offer of $75 in cash and 2.3 Mylan shares for each Perrigo share. (Photograph: Mannie Garcia/Bloomberg News)

Mylan’s chairman told investors he may sweeten the company’s cash-and-stock offer for Irish headquartered Perrigo by adding terms to reduce the risk (...)

Robert J. Coury, vice-chairman and chief executive of Mylan. Photographer: Mannie Garcia/Bloomberg News

Generic drugs group Mylan boosted its cash-and-stock offer to buy Irish company Perrigo to $34.10 billion, but the bid was swiftly rejected.Mylan’s p(...)

Robert Coury, chief executive of Mylan pharmacutical company. Photograph: Alan Betson / THE IRISH TIMES

Generic drugmaker Mylan says it will take its $31 billion offer for Perrigo directly to shareholders, in what is set to be one of the most high-profil(...)

Joe Papa CEO and president of Perrigo, which has rejected a $29 billion bid from rival Mylan. Photograph: Brenda Fitzsimons / THE IRISH TIMES

Dublin-based Perrigo has rejected a $29 billion bid from generics group Mylan. The company said its board unanimously rejected the $205 per share offe(...)

Joe Papa, CEO and president of Perrigo

The ripple effect of the wave of corporate inversion in the pharma/medtech sector continues to drive the ongoing wave of consolidation.Less than two y(...)

A generic form of the drug Plavix sits on crates at a Mylan Pharmaceuticals distribution centre in North Carolina.  Mylan has offered to acquire Perrigo for about $29 billion in what would be the latest mega-merger among drug makers if it is completed. Photograph: Travis Dove/The New York Times

Drugmaker Mylan offered to buy rival Perrigo for $28.9 billion in a deal that would create a powerhouse for generic medicine. Mylan, which makes abo(...)

Joe Papa CEO and president of Perrigo, which has announced it will acquire Belgium’s Omega Pharma in a €3.6 billion deal.  Photograph: Brenda Fitzsimons / THE IRISH TIMES

Perrigo, the Irish-domiciled consumer pharma group that bought Elan last year, has announced plans to acquire Belgium’s Omega Pharma for €3.6 billi(...)

Steven Cohen: a judge ruled yesterday that the entire case against him and SAC can go forward. Photograph: Scott Eells/Bloomberg

A US federal judge has rejected billionaire investor Steven A Cohen’s bid to dismiss lawsuits by shareholders of pharma firms Elan and Wyeth who clai(...)